Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
3(100.0%)
3Total
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02009345Recruiting

Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada

Role: collaborator

NCT02504736Completed

Colesevelam, Lipids And Sugars, South Asian Canadian Trial

Role: collaborator

NCT00272207Phase 2Completed

A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia

Role: collaborator

NCT00699634Phase 2Completed

Nabilone for the Treatment of Phantom Limb Pain

Role: collaborator

NCT00623376Phase 2Completed

Randomized Double Blind Cross Over Study for Nabilone in Spasticity in Spinal Cord Injury Persons

Role: collaborator

All 5 trials loaded